Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2019 2024

• 5 Active

Projects per year

A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Briggs, P.

1/11/19 → 31/10/24

Project: Research

CANOPY-1: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study Evaluating the Efficacy and Safety of Pembrolizumab plus Platinumbased Doublet Chemotherapy with or without Canakinumab as First Line Therapy for Locally Advanced or Metastatic Non-Squamous and Squamous Non-Small Cell Lung Cancer Subjects

Briggs, P.

20/09/19 → 19/09/24

Project: Research

A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination with Celecoxib and Gemcitabine in Patients with Malignant Pleural Mesothelioma

Briggs, P.

4/09/19 → 3/09/24

Project: Research

Randomized, multicenter, phase iii, open-label study of Alectinib versus Crizotinib in treatment-naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer

Briggs, P.

20/06/19 → 19/06/24

Project: Research

A Phase III, Double-Blind, Randomised Study to Assess the Efficacy and Safety of AZD9291 Versus a Standard of Care Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as First-Line Treatment In Patients with Epidermal Growth Factor Receptor Mutation Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer. (FLAURA Study)

Briggs, P.

26/02/19 → 25/02/24

Project: Research

Research Output 2019 2019

• 1 Meeting Abstract

Research Output per year

Implementation of an immune-related adverse events (irAE) education program for healthcare professionals at an Australian multisite tertiary health service

Davies, A., Kwan, E. M., Briggs, P. & Segelov, E., 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, S9, p. 191-192 2 p.

Research output: Contribution to journal › Meeting Abstract › Other › peer-review